Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide

The Journal of Pediatrics

Volumn 123, Issue 1, 1993, Pages 103-108

  Kinsella, John P ^a,b   Neish, Steven R ^a,b   Ivy, D Dunbar ^a,b   Shaffer, Elizabeth ^a,b   Abman, Steven H ^a,b  

^a Children's Hospital   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

AEROSOL; ARTICLE; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MECONIUM ASPIRATION; NEWBORN; NEWBORN SEPSIS; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; DRUG EVALUATION; ECHOCARDIOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMAN; INFANT, NEWBORN; NITRIC OXIDE; OXYGEN; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY INSUFFICIENCY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; VASODILATOR AGENTS;

EID: 0027193216     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)81551-3     Document Type: Article

References (25)

1. Refractory hypoxemia associated with neonatal pulmonary disease: the use and limitations of tolazoline
2. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension
3. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
4. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
5. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure—100 cases
6. Cardiac performance in ECMO candidates: echocardiographic predictors for ECMO
7. 2 as a predictor of pulmonary vascular hypoplasia in infants with congenital diaphragmatic hernia
8. Extracorporeal membrane oxygenation and congenital diaphragmatic hernia: should any infant be excluded?
9. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
10. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep
11. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation
12. Biological actions and properties of endothelial-derived nitric oxide formed and released from artery and vein
13. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
14. EDRF and the pulmonary circulation
15. Role of EDRF during transition of pulmonary circulation at birth
16. Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery
17. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide
18. Adjustment of ventilation and perfusion in the full-term normal and distressed neonate as determined by urinary alveolar nitrogen gradients
19. Effects of PEEP and tolazoline infusion on respiratory and inert gas exchange in experimental meconium aspiration
20. Recommendations for occupational safety and health standards
21. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide
22. Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung
23. High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure
24. HFOV vs. IMV: early hemodynamic effects in the premature baboon with HMD